MedTrace Logo

A Methadone Maintenance Treatment Outcome Study in Three Provinces in China

NCT01315054 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 4258

Last updated 2024-08-22

No results posted yet for this study

Summary

The primary goal of this PHE is to determine the effectiveness of a tailored education program for MMT service providers. It was to be evaluated through methadone dose levels prescribed to new patients after training completion. The effects of methadone dose, with and without the inclusion of additional counseling services, would be measured through MMT retention and illicit opioid use.

Conditions

  • HIV
  • Hepatitis C
  • Syphilis
  • Herpes Simplex Type II

Interventions

BEHAVIORAL

MMT provider dosage training

Training on methadone dosing provided to health care providers working in methadone maintenance clinics

BEHAVIORAL

targeted counseling

targeted counseling provided to methadone maintenance clinic attendees

OTHER

national guidelines

Provided a hard copy of the existing national guidelines for methadone dosing

Sponsors & Collaborators

Principal Investigators

  • Marc Bulterys, MD, PhD · US CDC GAP China

Study Design

Allocation
RANDOMIZED
Purpose
HEALTH_SERVICES_RESEARCH
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2011-05-31
Primary Completion
2015-12-31
Completion
2018-12-31

Countries

  • China

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01315054 on ClinicalTrials.gov